A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates.

@article{BoyleVavra2001ASO,
  title={A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates.},
  author={Susan Boyle-Vavra and Harald Labischinski and Christine C. Ebert and Kerstin Ehlert and Robert S. Daum},
  journal={Antimicrobial agents and chemotherapy},
  year={2001},
  volume={45 1},
  pages={280-7}
}
The mechanism of glycopeptide resistance in Staphylococcus aureus is not known with certainty. Because the target of vancomycin is the D-Ala-D-Ala terminus of the stem peptide of the peptidoglycan precursor, by subjecting muropeptides to reversed-phase high-performance liquid chromatography, we investigated peptidoglycan obtained from glycopeptide-intermediate S. aureus (GISA) isolates for changes in composition and evaluated whether any peptidoglycan structural change was a consistent feature… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
35 Extracted Citations
22 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 35 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 22 references

Similar Papers

Loading similar papers…